Assignee
D3 BIO WUXI CO LTD
CN·4 granted patents·7 pending applications·1 citations·filing 2020–2025
Top patents by PatentIndex Score
11 records- 0188US12012404B2Pyrimidoheterocyclic compounds and application thereofD3 BIO WUXI CO LTD·Filed 2023·Granted Jun 18, 2024·1 cites·30 claims
- 0277US2025154151A1Pyrimidoheterocyclic compounds and application thereofD3 BIO WUXI CO LTD·Filed 2024·Application pending·0 cites
- 0365US12162880B2Pyrimidoheterocyclic compounds and application thereofD3 BIO WUXI CO LTD·Filed 2021·Granted Dec 10, 2024·0 cites·20 claims
- 0460US2024300975A1Dimethyl-substituted thiazololactam compound and use thereofD3 BIO WUXI CO LTD·Filed 2022·Application pending·0 cites
- 0560US2024309018A1Thiazole-lactam-spiroheterocyclic compounds and applications thereofD3 BIO WUXI CO LTD·Filed 2022·Application pending·0 cites
- 0659US2025109146A1Bridged ring-substituted heteroaryl-pyran derivative, and use thereofD3 BIO WUXI CO LTD·Filed 2023·Application pending·0 cites
- 0758US2025129102A1Crystal form of pyrimidine heterocyclic compound and preparation method thereforD3 BIO WUXI CO LTD·Filed 2022·Application pending·0 cites
- 0854US2025066387A9Pyrimidopyran compoundD3 BIO WUXI CO LTD·Filed 2022·Application pending·0 cites
- 0953US12398153B2Spiro compound serving as ERK inhibitor, and application thereofD3 BIO WUXI CO LTD·Filed 2020·Granted Aug 26, 2025·0 cites·14 claims
- 1052US12522616B2Thiazololactam compound as ERK inhibitor and use thereofD3 BIO WUXI CO LTD·Filed 2020·Granted Jan 13, 2026·0 cites·18 claims
- 1146US2025228854A1Heterocyclic substituted pyrimidopyran compounds and their applicationsD3 BIO WUXI CO LTD·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when D3 BIO WUXI CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →